Sarah Burgess
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes 8
- Hepatology top 10%
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases 4
-
- Adolescent Sexual and Reproductive Health 4
- Health Policy Implementation Science 3
-
- Alzheimer's disease research and treatments 4
-
- Computational Drug Discovery Methods 3
-
- Global Maternal and Child Health 3
-
- Nicotinic Acetylcholine Receptors Study 3
- Co-authors
- Valentina Echeverrı́aGary W. ArendashRoss ZeitlinEric M. YoshidaTrana HussainiJoyonna Gamble‐GeorgePeter J. ZedErik Vu
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Sarah Burgess
28 papers receiving 588 citations
Peers
Comparison fields: 5 of 114
- Geriatrics and Gerontology 58
- Hepatology 83
- Applied Microbiology and Biotechnology 17
- Biological Psychiatry 19
- Pharmacology 95
Countries citing papers authored by Sarah Burgess
This map shows the geographic impact of Sarah Burgess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Burgess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Burgess more than expected).
Fields of papers citing papers by Sarah Burgess
This network shows the impact of papers produced by Sarah Burgess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Burgess. The network helps show where Sarah Burgess may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Burgess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 17 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 11 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 40 | |
| 10 | Key Priorities to Implement Deprescribing in Primary Health Care in Nova Scotia: Results from the Deprescribing in Primary Health Care in Nova Scotia Knowledge Exchange Event (June 20, 2019) | 2020 | 0 |
| 11 | 2018 | 7 | |
| 12 | 2017 | 11 | |
| 13 | 2016 | 12 | |
| 14 | 2012 | 7 | |
| 15 | 2011 | 74 | |
| 16 | 2011 | 66 | |
| 17 | 2010 | 13 | |
| 18 | Effective Organizational Practices for Middle and High School Grades: A Qualitative Study of What's Helping Philadelphia Students Succeed in Grades 6-12. | 2009 | 0 |
| 19 | 2009 | 62 | |
| 20 | 2008 | 13 |
About Sarah Burgess
Sarah Burgess is a scholar working on Geriatrics and Gerontology, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 32 papers that have together received 601 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (8 papers), Adolescent Sexual and Reproductive Health (4 papers), Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Health Policy Implementation Science (3 papers), Computational Drug Discovery Methods (3 papers), Global Maternal and Child Health (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). The work is most often cited by research in Geriatrics and Gerontology (58 citations), Hepatology (83 citations) and Applied Microbiology and Biotechnology (17 citations). Sarah Burgess has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Valentina Echeverrı́a, Gary W. Arendash, Ross Zeitlin, Eric M. Yoshida, Trana Hussaini, Joyonna Gamble‐George, Peter J. Zed, Erik Vu, Richard S Slavik and Riyad B. Abu‐Laban.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.